| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
31,330 |
21,059 |
$1.77M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
34,817 |
22,343 |
$1.52M |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
14,695 |
12,887 |
$1.39M |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
4,591 |
4,184 |
$956K |
| 90832 |
Psychotherapy, 30 minutes with patient |
7,490 |
5,974 |
$237K |
| T1007 |
Alcohol and/or substance abuse services, treatment plan development and/or modification |
3,716 |
3,431 |
$206K |
| T2023 |
Targeted case management; per month |
531 |
491 |
$159K |
| H0015 |
Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education |
1,602 |
301 |
$154K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
7,413 |
5,625 |
$93K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
460 |
428 |
$86K |
| 90791 |
Psychiatric diagnostic evaluation |
1,279 |
1,098 |
$79K |
| 90834 |
Psychotherapy, 45 minutes with patient |
1,761 |
1,424 |
$76K |
| 90837 |
Psychotherapy, 53 minutes with patient |
901 |
653 |
$57K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
883 |
726 |
$26K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
124 |
109 |
$14K |
| 90838 |
|
283 |
261 |
$14K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
196 |
183 |
$9K |
| H0049 |
Alcohol and/or drug screening |
603 |
374 |
$7K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
215 |
165 |
$5K |
| 81025 |
|
701 |
671 |
$5K |
| 99354 |
|
72 |
68 |
$4K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
45 |
38 |
$3K |
| 99215 |
Prolong outpt/office vis |
15 |
15 |
$1K |
| H0001 |
Alcohol and/or drug assessment |
38 |
36 |
$1K |
| 96127 |
|
284 |
230 |
$243.33 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
15 |
13 |
$127.40 |
| 90836 |
|
16 |
15 |
$87.39 |